- Home
- MDT vs METAM Comparison
MDT vs METAM Comparison
Compare MDT & METAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
METAM
Meta Platforms Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock
Current Price
Company Overview
Basic Information| Metric | MDT | METAM |
|---|---|---|
| Founded | 1949 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.2B | 125.8B |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MDT | METAM |
|---|---|---|
| Price | $101.35 | $51.54 |
| Analyst Decision | Buy | |
| Analyst Count | 30 | 0 |
| Target Price | ★ $105.00 | N/A |
| AVG Volume (30 Days) | ★ 12.9M | 3.4M |
| Earning Date | 11-24-2026 | N/A |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ 3.32 | N/A |
| EPS | 1.14 | ★ 20.44 |
| Revenue | $36,364,000,000.00 | ★ $40,653,000,000.00 |
| Revenue This Year | $7.17 | N/A |
| Revenue Next Year | $3.67 | N/A |
| P/E Ratio | $90.42 | ★ $2.52 |
| Revenue Growth | 8.43 | ★ 47.09 |
| 52 Week Low | $73.31 | $50.05 |
| 52 Week High | $106.33 | $51.66 |
Technical Indicators
Market Signals| Indicator | MDT | METAM |
|---|---|---|
| Relative Strength Index (RSI) | 61.18 | N/A |
| Support Level | $85.31 | N/A |
| Resistance Level | $105.50 | N/A |
| Average True Range (ATR) | 2.38 | 0.00 |
| MACD | 0.52 | 0.00 |
| Stochastic Oscillator | 62.38 | 0.00 |
Price Performance
Historical ComparisonAbout MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.